RNU4-9P: A Drug Target / Disease Biomarker (G100862675)

Target Name: RNU4-9P

NCBI ID: G100862675

RNU4-9P

Other Name(s): RNA, U4 small nuclear 9, pseudogene

RNU4-9P: A Drug Target / Disease Biomarker

RNA-Nucleic Acid-4 (RNA-NAC-4) is a non-coding RNA molecule that has been identified as a potential drug target or biomarker. It is a small molecule that can interact with various proteins, including the transcription factor RNA-Nucleic Acid-binding protein (RNASET), which plays a crucial role in the regulation of gene expression.

RNA-NAC-4 is a small molecule that can interact with RNASET, a protein that is known to play a critical role in the regulation of gene expression. RNASET is a transcription factor that is involved in the regulation of gene expression by binding to specific DNA sequences. It is known to interact with various proteins, including RNA-NAC-4, which suggests that RNA-NAC-4 may be a drug target or biomarker.

One of the potential benefits of identifying RNA-NAC-4 as a drug target is that it can be used to develop new treatments for various diseases. RNA-NAC-4 is involved in the regulation of gene expression, which suggests that it may be involved in the development of some diseases. For example, RNA-NAC-4 has been shown to be involved in the regulation of cancer cell growth and has been identified as a potential drug target for cancer.

In addition to its potential as a drug target, RNA-NAC-4 has also been identified as a potential biomarker for certain diseases. RNA-NAC-4 has been shown to be involved in the regulation of gene expression in various diseases, including cancer, neurodegenerative diseases, and metabolic diseases. This suggests that RNA-NAC-4 may be a useful biomarker for these diseases.

RNA-NAC-4 is also a small molecule that can be used to study the regulation of gene expression. By studying how RNA-NAC-4 interacts with RNASET, researchers can gain insights into the regulation of gene expression and identify new potential drug targets or biomarkers.

In conclusion, RNA-NAC-4 is a small molecule that has been identified as a potential drug target or biomarker. Its interaction with RNASET suggests that it may be involved in the regulation of gene expression and could be a useful target for new treatments for various diseases. Further research is needed to fully understand the regulation of gene expression by RNA-NAC-4 and to identify its potential as a drug target or biomarker.

Protein Name: RNA, U4 Small Nuclear 9, Pseudogene

The "RNU4-9P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RNU4-9P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets